MEDVET SCIENCE PTY LTD

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 10245
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 7199
 
  
 
C07K PEPTIDES 6130
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 4121
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 1239
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
C12M APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY 148

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0218,340 METHOD OF CULTURING CELLSMay 11, 15Aug 03, 17[A61K, C12N]
2016/0053,318 MARKERS OF ENDOTHELIAL PROGENITOR CELLS AND USES THEREOFSep 04, 15Feb 25, 16[A61K, C12Q, G01N]
2010/0310,450 METHOD OF DIAGNOSIS AND AGENTS USEFUL FOR SAMEOct 11, 07Dec 09, 10[A61K, C12Q, G01N]
2010/0135,903 USE OF A DNA DAMAGING AGENT AND A LIGAND FOR THE TREATMENT OF CANCEROct 11, 07Jun 03, 10[A61K, A61P]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920371 Screening methodSep 21, 12Mar 20, 18[C12Q, G01N, C07K]
9605079 Proteins that bind PI16 and uses thereofApr 18, 11Mar 28, 17[A61K, C12N, G01N, C07K]
9063155 Immunotherapeutic method of treating neoplastic conditionsFeb 23, 04Jun 23, 15[A61K, G01N, C07K]
8697702 Method of optimizing the treatment of Philadelphia-positive leukemia with imatinib mesylateNov 30, 09Apr 15, 14[A61K]
7863034 Microbial streaking deviceJul 21, 06Jan 04, 11[C12M]
7427401 Method of modulating leukemic cell and eosinphil activity with monoclonal antibodiesFeb 09, 04Sep 23, 08[A61K]
RE39433 Therapeutic agents as cytokine antagonists and agonistsJan 29, 97Dec 19, 06[A61K]
6720155 Monoclonal antibody inhibitor of GM-CSF, IL-3, IL-5 and other cytokines, and uses thereofFeb 14, 01Apr 13, 04[G01N, C07K]
6649362 Screening method for an agent having an effect on a sphingosine kinase signaling pathwayOct 16, 01Nov 18, 03[C12Q]
6200567 Therapeutic agents as cytokine antagonists and agonistsJul 29, 98Mar 13, 01[A61K, G01N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0348,793 Method of TreatmentAbandonedDec 13, 12Nov 27, 14[A61K]
2013/0231,305 Method of Modulating Protein 14-3-3 Functionality By Facilitating or Inhibiting PhosphorylationAbandonedMar 29, 11Sep 05, 13[A61K, C12Q]
2013/0224,116 Markers of Endothelial Progenitor Cells and Uses ThereofAbandonedNov 07, 11Aug 29, 13[A61K, C12Q, C12N, G01N, C07K]
2012/0064,100 BIOMARKERS AND USES THEREOFAbandonedMar 18, 10Mar 15, 12[A61K, C12Q, C12N, G01N, A61P, C40B]
2010/0260,744 REGULATING IL-4 AND IL-13 LEVELS BY BLOCKING HIGH AFFINITY BINDING BY IL-3, IL-5 AND GM-CSF TO THEIR COMMON RECEPTORAbandonedJul 10, 08Oct 14, 10[A61K, A61P]
2010/0184,779 METHOD FOR OPTIMIZING THE TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH ABL TYROSINE KINASE INHIBITORSAbandonedJun 20, 08Jul 22, 10[A61K, A61P]
2010/0088,775 METHODS OF MODULATING EPITHELIAL-MESENCHYMAL TRANSITION AND MESENCHYMAL-EPITHELIAL TRANSITION IN CELLS AND AGENTS USEFUL FOR THE SAMEAbandonedMay 25, 07Apr 08, 10[A61K, C12N, A01K, A61P]
2009/0214,420 Method of Diagnosis and Treatment and Agents Useful for SameAbandonedMar 31, 06Aug 27, 09[A61K, C12Q, A61P]
2008/0279,841 Novel Therapeutic Molecular Variants And Uses ThereofAbandonedJun 20, 01Nov 13, 08[A61K, C12Q, C12N, G01N]
2008/0279,897 Method of Treating Cellular DamageAbandonedJan 17, 06Nov 13, 08[A61K, C12N, A61P]
2007/0265,196 Method of Modulating Pro-Inflammatory and Inflammatory Activity Mediated by C-Reactive ProteinAbandonedJan 21, 05Nov 15, 07[A61K, C12N, A61P]
2007/0219,117 BIDENTATE MOTIF AND METHODS OF USEAbandonedOct 27, 04Sep 20, 07[C07K]
2007/0116,687 Method of modulating cellular transmigration and agents for use thereinAbandonedMay 13, 04May 24, 07[A61K]
7220829 Cytokine binding domain of cytokine receptorsExpiredAug 08, 01May 22, 07[C07K]
2007/0059,796 Binding motif and methods of regulating cell functionAbandonedOct 27, 04Mar 15, 07[A61K, C07H, C12P, C07K]
2006/0264,362 Method of modulating smooth muscle cell functioning by modulating sphingosine kinase mediated signallingAbandonedMar 18, 04Nov 23, 06[A61K]
2006/0205,688 Method of modulating epithelial cell activity by modulating the functional levels of sphingosine kinaseAbandonedOct 14, 03Sep 14, 06[A61K]
2006/0111,286 Method of modulating endothelial cell activityAbandonedSep 05, 03May 25, 06[A61K]
2005/0100,547 Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activityAbandonedOct 14, 04May 12, 05[A61K]
2005/0009,732 Method of treatment and agents useful for sameAbandonedFeb 19, 04Jan 13, 05[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.